Bank of New York Mellon’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,965,338
Closed -$592M 4325
2019
Q3
$592M Sell
5,965,338
-14,291
-0.2% -$1.36M 0.16% 119
2019
Q2
$553M Sell
5,979,629
-109,540
-2% -$10.4M 0.15% 127
2019
Q1
$574M Sell
6,089,169
-339,140
-5% -$29.7M 0.16% 122
2018
Q4
$412M Buy
6,428,309
+161,938
+3% +$12M 0.13% 148
2018
Q3
$561M Sell
6,266,371
-267,544
-4% -$23.6M 0.14% 130
2018
Q2
$519M Sell
6,533,915
-487,641
-7% -$40.5M 0.14% 140
2018
Q1
$626M Sell
7,021,556
-1,771,433
-20% -$170M 0.17% 113
2017
Q4
$918M Sell
8,792,989
-715,787
-8% -$80.8M 0.24% 78
2017
Q3
$1.39B Sell
9,508,776
-142,020
-1% -$19.3M 0.38% 53
2017
Q2
$1.25B Sell
9,650,796
-437,677
-4% -$53.6M 0.35% 58
2017
Q1
$1.26B Buy
10,088,473
+472,067
+5% +$56.5M 0.35% 57
2016
Q4
$1.11B Buy
9,616,406
+155,475
+2% +$17.3M 0.32% 65
2016
Q3
$989M Buy
9,460,931
+1,567,515
+20% +$170M 0.29% 71
2016
Q2
$779M Sell
7,893,416
-88,556
-1% -$9.16M 0.24% 86
2016
Q1
$799M Sell
7,981,972
-841,275
-10% -$86.6M 0.24% 85
2015
Q4
$1.06B Sell
8,823,247
-439,768
-5% -$50.9M 0.32% 68
2015
Q3
$1B Sell
9,263,015
-602,643
-6% -$74.8M 0.31% 66
2015
Q2
$1.14B Sell
9,865,658
-1,539,630
-13% -$176M 0.31% 66
2015
Q1
$1.32B Sell
11,405,288
-482,839
-4% -$57.7M 0.34% 63
2014
Q4
$1.33B Buy
11,888,127
+862,028
+8% +$90.9M 0.35% 59
2014
Q3
$1.05B Buy
11,026,099
+616,711
+6% +$55.7M 0.28% 73
2014
Q2
$894M Sell
10,409,388
-163,804
-2% -$12.5M 0.24% 85
2014
Q1
$738M Sell
10,573,192
-1,428,308
-12% -$113M 0.2% 98
2013
Q4
$1.01B Sell
12,001,500
-369,422
-3% -$29.2M 0.28% 72
2013
Q3
$953M Buy
12,370,922
+409,918
+3% +$28.7M 0.28% 71
2013
Q2
$700M Buy
+11,961,004
New +$720M 0.22% 91

Other funds holding CELG

Bank of New York Mellon's CELG Position: Q4 2019 in Review

Bank of New York Mellon sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,965,338 shares — an estimated $592M sold.

Bank of New York Mellon first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.39B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bank of New York Mellon reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 5,965,338 Celgene Corp shares in Q4 2019, an estimated $592M.
  • Bank of New York Mellon first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bank of New York Mellon's Celgene Corp position peaked at $1.39B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.